Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: A randomized, double-blind, placebo-controlled, crossover trial

American Journal of Gastroenterology

Volumn 105, Issue 7, 2010, Pages 1504-1512

  Lee, Hyuk ^a,b   Kim, Jeong Hwan ^c   Min, Byung Hoon ^a   Lee, Jun Haeng ^a   Son, Hee Jung ^a   Kim, Jae J ^a   Rhee, Jong Chul ^a   Suh, Young Ju ^d   Kim, Seonwoo ^d   Rhee, Poong Lyul ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Armed Forces Capital Hospital   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VENLAFAXINE;

ADULT; ANALGESIA; ANOREXIA; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FUNCTIONAL CHEST PAIN; GASTROINTESTINAL ENDOSCOPY; HUMAN; MALE; MOOD DISORDER; NAUSEA; OUTCOME ASSESSMENT; PLACEBO EFFECT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SIDE EFFECT; SLEEP DISORDER; SWEATING; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; ANXIETY; CHEST PAIN; CHI-SQUARE DISTRIBUTION; CROSS-OVER STUDIES; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; DEPRESSION; DOUBLE-BLIND METHOD; ESOPHAGEAL DISEASES; ESOPHAGEAL PH MONITORING; FEMALE; HUMANS; MALE; MANOMETRY; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77954423802     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.82     Document Type: Article

References (43)

1. 1504-1512 Eslick GD, Coulshed DS, Talley NJ. Review article: the burden of illness of non-cardiac chest pain. Aliment Pharmacol Ther 2002;16:1217-1223
2. Eslick GD, Fass R. Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am 2003;32:531-552
3. Williams J F, Sontag SJ, Schnell T et al. Non-cardiac chest pain: the long- term natural history and comparison with gastroesophageal refux disease. Am J Gastroenterol 2009;104:2145-2152
4. Drossman DA, Li Z, Andruzzi E et al. U.S. householder survey of func- tional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580
5. Ockene IS, Shay M J, Alpert J S et al. Unexplained chest pain in patients with normal coronary arteriograms: a follow-up study of functional status. N Engl J Med 1980;303:1249-1252
6. Ward BW, Wu WC, Richter J E et al. Long-term follow-up of symptomatic status of patients with noncardiac chest pain: is diagnosis of esophageal etiology helpful? Am J Gastroenterol 1987;82:215-218
7. Galmiche JP, Clouse RE, Balint A et al. Functional esophageal disorders. Gastroenterology 2006;130:1459-1465
8. Anand P, Aziz Q, Willert R et al. Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterol Motil 2007; 19: 29-46.
9. Rao S S, Gregersen H, Hayek B et al. Unexplained chest pain: the hyper- sensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med 1996;124:950-958
10. Rao SS, Hayek B, Summers RW. Functional chest pain of esophagealo rigin: hyperalgesia or motor dysfunction. Am J Gastroenterol 2001;96:2584-2589
11. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986; 91: 845-852
12. Sarkar S, Aziz Q, Woolf CJ et al. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 2000; 356: 1154-1159
13. Clouse RE, Lustman PJ, Eckert T C et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 1987;92:1027-1036
14. Cannon RO III, Quyyumi AA, Mincemoyer R et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994;330:1411-1417
15. Prakash C, Clouse RE. Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci 1999;44:2373-2379
16. Gutierrez MA, Stimmel GL, Aiso JY. Venlafaxine: a 2003 update. Clin Ter 2003;25:2138-2154
17. Sindrup SH, Bach FW, Madsen C et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 2003;60:1284-1289
18. Sumpton JE, Moulin DE. Treatment of neuropathic pain with venlafaxine. Ann Pharmacother 2001; 35: 557-559
19. Rao SS, Mudipalli RS, Mujica VR et al. Effects of gender and age on esophageal biomechanical properties and sensation. Am J Gastroenterol 2003;98:1688-1695
20. Phan A, Shufelt C, Merz CN. Persistent chest pain and no obstructive coronary artery disease. JAMA 2009; 301: 1468-1474
21. Beck AT, Ward CH, Mendelson M et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
22. Fass R, Fennerty M B, Ofman JJ et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998;115:42-49
23. Lee H, Kim JH, Sung I K et al. Effect of amitriptyline on symptom response of patients with gastroesophageal ref ux-negative non-cardiac chest pain \- a randomized, double blind, placebo-controlled, crossover trial. GUT 2007;56 (Suppl III): a6.
24. Jones B, Kenward MG. Design and Analysis of Cross-Over Trials. Chapman & Hall/CRC, London, 2003. Achem SR. New frontiers for the treatment of noncardiac chest pain: the adenosine receptors. Am J Gastroenterol 2007;102:939-941
25. Fass R, Dickman R. Non-cardiac chest pain: an update. Neurogastroenterol Motil 2006;18:408-417
26. Achem SR, DeVault KR. Recent developments in chest pain of undetermined origin. Curr Gastroenterol Rep 2000; 2: 201-209
27. Van Handel D, Fass R. The pathophysiology of non-cardiac chest pain. J Gastroenterol Hepatol 2005;20 Suppl: S6-13.
28. Miller CD, Lindsell CJ, Khandelwal S et al. Is the initial diagnostic impression of "noncardiac chest pain" adequate to exclude cardiac disease? Ann Emerg Med 2004;44:565-574
29. Pandak WM, Arezo S, Everett S et al. Short course of omeprazole: a bet- ter f rst diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol 2002;35:307-314
30. Bautista J, Fullerton H, Briseno M et al. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain-a randomized, double-blind, placebo-controlled, crossover trial. Aliment Phar macol Ter 2004;19:1123-1130
31. Dickman R, Emmons S, Cui H et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Phar macol Ter 2005;22:547-555
32. Fass R, Nalibof B, Higa L et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998;115:1363-1373
33. Rao SS, Mudipalli RS, Remes-Troche JM et al. T eophylline improves esophageal chest pain-a randomized, placebo-controlled study. Am J Gastroenterol 2007;102:930-938
34. Schmulson MJ, Valdovinos MA. Current and future treatment of chest pain of presumed esophageal origin. Gastroenterol Clin North Am 2004;33: 93-105.
35. Varia I, Logue E, O'Connor C et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000;140:367-372
36. Broekaert D, Fischler B, Sifrim D et al. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2006;23:365-370 (Pubitemid 43382016)
37. Schreiber S, Backer MM, Pick CG. The antinociceptive effect of venlafaxine in mice is mediated through opioid and adrenergic mechanisms. Neurosci Lett 1999;273:85-88
38. Markowitz JS, Patrick KS. Venlafaxine-tramadol similarities. Med Hypotheses 1998;51:167-168
39. van Kerkhoven LA, Laheij RJ, Aparicio N et al. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2008;6:746-52; quiz 718.
40. Huang WW, Zhou FS, Bushnell D M et al. Cultural adaptation and applica- tion of the IBS-QOL in China: a disease-specific quality-of-life questionnaire. Qual Life Res 2007;16:991-996
41. Enck P, Klosterhalfen S. The placebo response in functional bowel disor- ders: perspectives and putative mechanisms. Neurogastroenterol Motil 2005;17:325-331
42. Targownik LE, Bolton J M, Metge C J et al. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 2009; 104: 1475-1482
43. van Soest EM, Dieleman JP, Siersema PD et al. Tricyclic antidepressants and the risk of refux esophagitis. Am J Gastroenterol 2007;102:1870-1877